[
1. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol 2022;95(1130):20211033.10.1259/bjr.20211033882255134905391
]Search in Google Scholar
[
2. Beňačka R, Szabóová D, Guľašová Z, Hertelyová Z, Radoňák J. Classic and new markers in diagnostics and classification of breast cancer. Cancers (Basel) 2022;14(21):5444.10.3390/cancers14215444965419236358862
]Search in Google Scholar
[
3. Araújo T, Aresta G, Castro E, Rouco J, Aguiar P, Eloy C, et al. Classification of breast cancer histology images using Convolutional Neural Networks. PLoS One 2017;12(6):e0177544.10.1371/journal.pone.0177544545342628570557
]Search in Google Scholar
[
4. Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J 2009;15(6):593-602.10.1111/j.1524-4741.2009.00822.x19764994
]Search in Google Scholar
[
5. Grogan Fleege NM, Cobain EF. Breast cancer management in 2021: A primer for the obstetrics and gynecology. Best Pract Res Clin Obstet Gynaecol 2022;82:30-45.10.1016/j.bpobgyn.2022.02.00435307285
]Search in Google Scholar
[
6. Sonnenblick EB, Shah AD, Goldstein Z, Reisman T. breast imaging of transgender individuals: a review. Curr Radiol Rep 2018;6(1):1.10.1007/s40134-018-0260-1577361629392096
]Search in Google Scholar
[
7. Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat 2019;173(1):37-48.10.1007/s10549-018-4921-9751379730267249
]Search in Google Scholar
[
8. Yoney A, Kucuk A, Unsal M. Male breast cancer: a retrospective analysis. Cancer Radiother 2009;13(2):103-7.10.1016/j.canrad.2008.11.01119250851
]Search in Google Scholar
[
9. Bedrick BS, Fruhauf TF, Martin SJ, Ferriss JS. Creating breast and gynecologic cancer guidelines for transgender patients with BRCA mutations. Obstet Gynecol 2021;138(6):911-7.10.1097/AOG.000000000000459734735408
]Search in Google Scholar
[
10. Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2007;99(23):1811-4.10.1093/jnci/djm203226728918042939
]Search in Google Scholar
[
11. Kim SW, Kim TH, Han JY, Kim SK, Lee JR, Jee UC, et al. Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation. Gynecol Endocrinol 2022;38(3):227-30.10.1080/09513590.2021.200229434775902
]Search in Google Scholar
[
12. Fentiman IS. The biology of male breast cancer. Breast 2018;38:132-5.10.1016/j.breast.2018.01.00129316513
]Search in Google Scholar
[
13. de Blok CJM, Wiepjes CM, Nota NM, van Engelen K, Adank MA, Dreijerink KMA, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ 2019;365:l1652.10.1136/bmj.l1652651530831088823
]Search in Google Scholar
[
14. Baker KE, Wilson LM, Sharma R, Dukhanin V, McArthur K, Robinson K. Hormone therapy, mental health, and quality of life among transgender people: a systematic review. J Endocr Soc 2021; 5(4):bvab011.10.1210/jendso/bvab011789424933644622
]Search in Google Scholar
[
15. Wiepjes CM, Nota NM, de Blok CJM, Klaver M, de Vries ALC, Wensing-Kruger SA, et al. The Amsterdam cohort of gender dysphoria study (1972–2015): Trends in prevalence, treatment, and regrets. J Sex Med 2018;15(4):582-90.10.1016/j.jsxm.2018.01.01629463477
]Search in Google Scholar
[
16. Gooren LJ. The care of transsexual persons. N Engl J Med 2011;364:1251-7.10.1056/NEJMcp100816121449788
]Search in Google Scholar
[
17. Fehl A, Ferrari S, Wecht Z, Rosenzweig M. Breast cancer in the transgender population. J Adv Pract Oncol 2019;10(4):387-94.
]Search in Google Scholar
[
18. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008;93(1):19-25.10.1210/jc.2007-180917986639
]Search in Google Scholar
[
19. Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol 2020;9(6):2771-85.10.21037/tau-20-954780731133457249
]Search in Google Scholar
[
20. Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, et al. Health considerations for transgender women and remaining unknowns: a narrative review. Ther Adv Endocrinol Metab 2019;10:2042018819871166.10.1177/2042018819871166671947931516689
]Search in Google Scholar
[
21. Safer JD. Research gaps in medical treatment of transgender/nonbinary people. J Clin Invest 2021;131(4):e142029.10.1172/JCI142029788030833586675
]Search in Google Scholar
[
22. Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat 2015;149(1):191-8.10.1007/s10549-014-3213-225428790
]Search in Google Scholar
[
23. Jackson SS, Han X, Mao Z, Nogueira L, Suneja G, Jemal A, et al. Cancer stage, treatment, and survival among transgender patients in the United States. J Natl Cancer Inst 2021;113(9):1221-7.10.1093/jnci/djab028852235233704460
]Search in Google Scholar
[
24. Cole NA, Copeland-Halperin LR, Shank N, Shankaran V. BRCA2-associated breast cancer in transgender women: Reconstructive challenges and literature review. Plast Reconstr Surg Glob Open 2022;10(4):e4059.10.1097/GOX.0000000000004059902998835475284
]Search in Google Scholar
[
25. Sieberg R, Soriano K, Zuurbier R. A rare case of breast cancer in a transgender woman. Radiol Case Rep 2021;16(11):3285-8.10.1016/j.radcr.2021.07.052840371734484532
]Search in Google Scholar
[
26. Lienhoop T, Smetko M, Green L. Breast cancer in transgender women: A case report. Clin Imaging 2020;68:20-3.10.1016/j.clinimag.2020.05.00632562922
]Search in Google Scholar
[
27. Nehlsen AD, Bhardwaj A, Weltz C, Green S. Triple negative breast cancer in a male to female transgender patient: a case report and literature review. Adv Radiat Oncol 2020;5(5):1083-9.10.1016/j.adro.2020.06.026755720333083671
]Search in Google Scholar
[
28. Patzelt M, Zarubova L, Klener P, Barta J, Benkova K, Brandejsova A, et al. Anaplastic large-cell lymphoma associated with breast implants: a case report of a transgender female. Aesthetic Plast Surg 2018;42(2):451-5.10.1007/s00266-017-1012-y29101436
]Search in Google Scholar
[
29. Tongson K, Konovalova V, Dhawan N, Sharma S, Bahl J, Masri M. Breast cancer suspicion in a transgender male-to-female patient on hormone replacement therapy presenting with right breast mass: Breast cancer risk assessment and presentation of a rare lesion. Case Rep Oncol Med 2017;2017:5172072.10.1155/2017/5172072537907928421153
]Search in Google Scholar
[
30. Corman V, Potorac I, Manto F, Dassy S, Segers K, Thiry A, et al. Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation. Endocr Relat Cancer 2016;23(5):391-7.10.1530/ERC-16-005727000661
]Search in Google Scholar
[
31. Gooren L, Bowers M, Lips P, Konings IR. Five new cases of breast cancer in transsexual persons. Andrologia 2015;47(10):1202-5.10.1111/and.1239925611459
]Search in Google Scholar
[
32. Teoh ZH, Archampong D, Gate T. Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature? BMJ Case Rep 2015;2015:bcr2015209396.10.1136/bcr-2015-209396444218025994431
]Search in Google Scholar
[
33. Sattari M. Breast cancer in male-to-female transgender patients: a case for caution. Clin Breast Cancer 2015;15(1):e67-9.10.1016/j.clbc.2014.08.00425445423
]Search in Google Scholar
[
34. Gondusky CJ, Kim MJ, Kalantari BN, Khalkhali I, Dauphine CE. Examining the role of screening mammography in men at moderate risk for breast cancer: two illustrative cases. Breast J 2015;21(3):316-7.10.1111/tbj.1241125882782
]Search in Google Scholar
[
35. Maglione KD, Margolies L, Jaffer S, Szabo J, Schmidt H, Weltz C, et al. Breast cancer in male-to-female transsexuals: use of breast imaging for detection. AJR Am J Roentgenol 2014;203(6):W735-40.10.2214/AJR.14.1272325415740
]Search in Google Scholar
[
36. Pattison ST, McLaren BR. Triple negative breast cancer in a male-to-female transsexual. Int Med J 2013;43(2):203-5.10.1111/imj.1204723402485
]Search in Google Scholar
[
37. Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: A systematic review. Part 1: Male to female. Eur J Surg Oncol 2018;44(10):1455-62.10.1016/j.ejso.2018.06.03530087072
]Search in Google Scholar
[
38. Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL. Breast cancer risk and screening in transgender persons: a call for inclusive care. Ann Surg Oncol 2022;29(4):2176-80.10.1245/s10434-021-10217-534097159
]Search in Google Scholar
[
39. Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA, et al. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. JAMA 2009;302(7):774-80.10.1001/jama.2009.1204346038319690310
]Search in Google Scholar
[
40. Gooren LJ, T’Sjoen G. Endocrine treatment of aging transgender people. Rev Endocr Metab Disord 2018;19(3):253-62.10.1007/s11154-018-9449-029922963
]Search in Google Scholar
[
41. Secreto G, Zumoff B. Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anti-cancer Res 2012;32(8):3223-8.
]Search in Google Scholar
[
42. Oberc A, Armstrong K, Ko HM, Grant A, Mullen JBM, Williams P. Case report of a breast granular cell tumor in a young transgender man. Int J Surg Case Rep 2022;93:106978.10.1016/j.ijscr.2022.106978897162235364393
]Search in Google Scholar
[
43. Fledderus AC, Gout HA, Ogilvie AC, van Loenen DKG. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast 2020;53:92-100.10.1016/j.breast.2020.06.008737564432679529
]Search in Google Scholar
[
44. Kopetti C, Schaffer C, Zaman K, Liapi S, di Summa PG, Bauquis O. Invasive breast cancer in a trans man after bilateral mastectomy: case report and literature review. Clin Breast Cancer 2020;21(3):e154-7.10.1016/j.clbc.2020.10.00533341378
]Search in Google Scholar
[
45. Light M, McFarlane T, Ives A, Shah B, Lim E, Grossmann M, et al. Testosterone therapy considerations in oestrogen, progesterone and androgen receptor-positive breast cancer in a transgender male. Clin Endocrinol (Oxf) 2020;93(3):355-7.10.1111/cen.1426332521051
]Search in Google Scholar
[
46. Chotai N, Tang S, Lim H, Lu S. Breast cancer in a female to male transgender patient 20 years post-mastectomy: issues to consider. Breast J 2019;25(6):1066-70.10.1111/tbj.1341731273889
]Search in Google Scholar
[
47. Fundytus A, Saad N, Logie N, Roldan Urgoiti G. Breast cancer in transgender female-to-male individuals: a case report of androgen receptor-positive breast cancer. Breast J 2020;26(5):1007-12.10.1111/tbj.1365531749246
]Search in Google Scholar
[
48. Tanini S, Fisher AD, Meattini I, Bianchi S, Ristori J, Maggi M, et al. Testosterone and breast cancer in transmen: case reports, review of the literature, and clinical observation. Clin Breast Cancer 2019;19(2):e271-5.10.1016/j.clbc.2018.12.00630655171
]Search in Google Scholar
[
49. Eismann J, Heng YJ, Fleischmann-Rose K, Tobias AM, Phillips J, Wulf GM, et al. Interdisciplinary management of transgender individuals at risk for breast cancer: Case Reports and review of the literature. Clin Breast Cancer 2019;19(1):e12-9.10.1016/j.clbc.2018.11.007708312930527351
]Search in Google Scholar
[
50. Barghouthi N, Turne J, Perini J. Breast cancer development in a transgender male receiving testosterone therapy. Case Rep Endocrinol 2018;2018:3652602.10.1155/2018/3652602633295430693115
]Search in Google Scholar
[
51. Treskova I, Hes O, Bursa V. Long-term hormonal therapy resulting in breast cancer in female-to-male transsexual: case report. Medicine (Baltimore) 2018;97(52):e13653.10.1097/MD.0000000000013653631469230593135
]Search in Google Scholar
[
52. Katayama Y, Motoki T, Watanabe S, Miho S, Kimata Y, Matsuoka J, et al. A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer 2016;23(6):939-44.10.1007/s12282-015-0661-426660332
]Search in Google Scholar
[
53. Nikolic DV, Djordjevic ML, Granic M, Nikolic AT, Stanimirovic VV, Zdravkovic D, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol 2012;10:280.10.1186/1477-7819-10-280355445923273269
]Search in Google Scholar
[
54. Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer 2011;11(6):417-9.10.1016/j.clbc.2011.06.00621831723
]Search in Google Scholar
[
55. Narayan A, Lebron-Zapata L, Morris E. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey. Breast Cancer Res Treat 2017;166(3):875-9.10.1007/s10549-017-4461-828828563
]Search in Google Scholar
